Stave Therapeutics Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Stave Therapeutics General Information

Description

Developer of novel therapeutics targeting inflammatory and autoimmune diseases designed to advance precision medicines from discovery through clinical development for patients with unmet medical needs. The company's proprietary drug discovery platform identifies and develops novel small-molecule and biological therapeutic candidates with precision targeting of inflammatory and autoimmune pathways, enabling clients to access differentiated treatments that address the underlying biology of their conditions and deliver improved efficacy and safety profiles.

Contact Information

Website
www.stavetx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Auckland
  • New Zealand
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Auckland
  • New Zealand

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stave Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 11-Jun-2026 Completed Pre-Clinical Trials
To view Stave Therapeutics’s complete valuation and funding history, request access »

Stave Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Auckland UniServices Corporate Venture Capital Minority
To view Stave Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Stave Therapeutics FAQs

  • When was Stave Therapeutics founded?

    Stave Therapeutics was founded in 2026.

  • Where is Stave Therapeutics headquartered?

    Stave Therapeutics is headquartered in Auckland, New Zealand.

  • What industry is Stave Therapeutics in?

    Stave Therapeutics’s primary industry is Biotechnology.

  • Is Stave Therapeutics a private or public company?

    Stave Therapeutics is a Private company.

  • What is Stave Therapeutics’s current revenue?

    The current revenue for Stave Therapeutics is .

  • Who are Stave Therapeutics’s investors?

    Auckland UniServices has invested in Stave Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process